Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer.
Fury MG, Sherman E, Lisa D, Agarwal N, Algazy K, Brockstein B, Langer C, Lim D, Mehra R, Rajan SK, Korte S, Lipson B, Yunus F, Tanvetyanon T, Smith-Marrone S, Ng K, Xiao H, Haque S, Pfister DG. Fury MG, et al. Among authors: lim d. J Natl Compr Canc Netw. 2012 Nov 1;10(11):1391-8. doi: 10.6004/jnccn.2012.0144. J Natl Compr Canc Netw. 2012. PMID: 23138167 Free PMC article. Clinical Trial.
Antiemesis.
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG, Lim D, Michaud LB, Nabati L, Noonan K, Rugo HS, Siler D, Sorscher SM, Stelts S, Stucky-Marshall L, Todaro B, Urba SG; National Comprehensive Cancer Network. Ettinger DS, et al. Among authors: lim d. J Natl Compr Canc Netw. 2012 Apr;10(4):456-85. doi: 10.6004/jnccn.2012.0047. J Natl Compr Canc Netw. 2012. PMID: 22491046 No abstract available.
Antiemesis. Clinical Practice Guidelines in Oncology.
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG, Lim D, Markiewicz MA, Nabati L, Nesheiwat C, Rugo HS, Sorscher SM, Stucky-Marshal L, Todaro B, Urba S. Ettinger DS, et al. Among authors: lim d. J Natl Compr Canc Netw. 2009 May;7(5):572-95. doi: 10.6004/jnccn.2009.0039. J Natl Compr Canc Netw. 2009. PMID: 19460282 No abstract available.
Senior adult oncology clinical practice guidelines in oncology.
Balducci L, Cohen HJ, Engstrom PF, Ettinger DS, Halter J, Gordon LI, Kiel K, Kneier A, Lim D, Petersdorf SH, Rosenthal R, Silliman R, Vose JM, Walker MJ, Zachariah B; National Comprehensive Cancer Network. Balducci L, et al. Among authors: lim d. J Natl Compr Canc Netw. 2005 Jul;3(4):572-90. doi: 10.6004/jnccn.2005.0032. J Natl Compr Canc Netw. 2005. PMID: 16038647 No abstract available.
Antiemesis clinical practice guidelines in oncology.
Ettinger DS, Bierman PJ, Bradbury B, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth D, Krauss A, Kris MG, Lim D, Markiewicz MA, McNulty R, Noonan K, Stucky-Marshall L, Todaro B, Urba S, Yowell S; National Comprehensive Cancer Network. Ettinger DS, et al. Among authors: lim d. J Natl Compr Canc Netw. 2004 Sep;2(5):470-90. doi: 10.6004/jnccn.2004.0037. J Natl Compr Canc Netw. 2004. PMID: 19780255 No abstract available.
NCCN Guidelines Insights: Antiemesis, Version 2.2017.
Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M. Berger MJ, et al. Among authors: lim d. J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117. J Natl Compr Canc Netw. 2017. PMID: 28687576
Antiemesis.
Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth DD, Kris MG, Lim D, Markiewicz MA, McNulty R, Nabati L, Todaro B, Urba S, Yowell S; National comprehensive Cancer Network (NCCN). Ettinger DS, et al. Among authors: lim d. J Natl Compr Canc Netw. 2007 Jan;5(1):12-33. doi: 10.6004/jnccn.2007.0004. J Natl Compr Canc Netw. 2007. PMID: 17239323 No abstract available.
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.
Ku G, Haag GM, Park H, Lam VK, George TJ, Kim SS, Gutierrez M, Shankaran V, Stein S, Denlinger CS, Elimova E, Nagrial A, He AR, Sawyer MB, Yoon HH, Geva R, Starr J, Curigliano G, Golan T, von Moos R, Fritsch R, Lim D, Wang Q, Patel A, Aoyama T, Lei M, Greenawalt D, Di Bartolomeo M. Ku G, et al. Among authors: lim d. ESMO Open. 2025 Jan 10;10(2):104107. doi: 10.1016/j.esmoop.2024.104107. Online ahead of print. ESMO Open. 2025. PMID: 39798422
4,795 results